Avalere: Many Seniors Would Pay More If Part B Drugs Moved To Part D

Many beneficiaries would pay much more for drugs if the administration moves doctor-administered Part B drugs into the Part D retail drug benefit, according to an Avalere analysis. HHS Secretary Alex Azar said that cutting drug prices is the president’s top health care priority, and that moving Part B drugs to Part D is the most important proposal in the administration’s plan to control drug costs. In the week after the release of its drug-price cutting plan, HHS published a...